OWLT
Owlet, Inc.NYSEHealthcare$5.10+0.20%ClosedMarket Cap: $92.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
81.04
P/S
0.87
EV/EBITDA
-8.95
DCF Value
$-1.13
FCF Yield
-12.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
50.6%
Operating Margin
-7.9%
Net Margin
-36.3%
ROE
239.7%
ROA
-45.6%
ROIC
-16.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $26.5M | 47.6% | $-4.9M | $-9.2M | $-0.07 | — |
| FY 2025 | $105.7M | 50.6% | $-8.3M | $-41.9M | $-2.24 | — |
| Q3 2025 | $32.0M | 50.6% | $1.2M | $4.1M | $0.19 | — |
| Q2 2025 | $26.1M | 51.2% | $-1.9M | $-36.3M | $-2.37 | — |
| Q1 2025 | $21.1M | 53.7% | $-2.7M | $3.0M | $0.11 | — |
| Q4 2024 | $20.5M | 53.7% | $-7.3M | $-9.1M | $-0.64 | — |
| FY 2024 | $78.1M | 50.4% | $-20.2M | $-12.5M | $-0.83 | — |
| Q3 2024 | $22.1M | 52.2% | $-4.8M | $-5.6M | $-0.61 | — |
| Q2 2024 | $20.7M | 49.5% | $-2.2M | $-1.1M | $-0.30 | — |
| Q1 2024 | $14.8M | 44.4% | $-5.7M | $3.3M | $-0.51 | — |
| Q4 2023 | $21.0M | 47.0% | $-3.1M | $-6.9M | $-0.97 | — |
| FY 2023 | $54.0M | 41.8% | $-28.6M | $-32.9M | $-4.53 | — |